［7］ Kent WD, Hall SF, Isotalo PA, et al. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease［J］. CMA J,2007,177(11): 1357-1361.
［8］ Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis［J］. N Engl J Med, 2014, 371(19): 1765-1767.
［9］ Amphlett B, Lawson Z, Abdulrahman GO, et al. Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010［J］. Thyroid, 2013,23(11): 1470-1478.
［10］ Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis［J］. Am J Surg, 2010, 200(4): 454-461.
［11］ Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015［J］. CA Cancer J Clin, 2016,66(2): 115-132.
［12］ Xhaard C, Rubino C, Cléro E, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: a population-based case-control study［J］. Am J Epidemiol, 2014,180(10): 1007-1017.
［13］ Fiore E, Rago T, Provenzale MA, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role［J］. Endocr Relat Cancer,2009,16(4): 1251-1260.
［14］ Schmid D, Ricci C, Behrens G, et al. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis［J］. Obes Rev, 2015, 16(12): 1042-1054.
［15］ Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update［J］. Thyroid,2014,24(2): 190-199.
［16］ Harikrishna A, Ishak A, Ellinides A, et al. The impact of obesity and insulin resistance on thyroid cancer: A systematic review［J］. Maturitas, 2019, 125(1)：45-49.
［17］ Shin HY, Jee YH, Cho ER. Body mass index and incidence of thyroid cancer in Korea: the Korean Cancer Prevention Study-II［J］. J Cancer Res Clin Oncol, 2017, 143(1): 143-149.
［18］ Hwang Y, Lee KE, Park YJ, et al. Annual Average Changes in Adult Obesity as a Risk Factor for Papillary Thyroid Cancer: A Large-Scale Case-Control Study［J］. Medicine (Baltimore), 2016,95(9): e2893.
［19］ Wu C, Wang L, Chen W, et al. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study［J］. Medicine (Baltimore), 2017,96(9): e6202.
［20］ Kim SK, Woo JW, Park I, et al. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma［J］. Thyroid,2016, 26(5): 657-666.
［21］ Kim HJ, Kim NK, Choi JH, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer［J］. Clin Endocrinol (Oxf),2013, 78(1): 134-140.
［22］ Harari A, Endo B, Nishimoto S, et al. Risk of advanced papillary thyroid cancer in obese patients［J］. Arch Surg, 2012,147(9): 805-811.
［23］ Paes JE, Hua K, Nagy R, et al. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study［J］. J Clin Endocrinol Metab, 2010, 95(9):4244-4250.
【相關|【中國實用外科雜志】肥胖代謝病合并甲狀腺癌外科治療中國專家共識（2021版）】［24］ Brito H, Santos AC, Preto J, et al. Obesity and cancer: the profile of a population who underwent bariatric surgery［J］. Obes Surg,2021, 31(11): 4682-4691.
［25］ 中華人民共和國衛生健康委員會.甲狀腺癌診療規范(2018年版) ［J］. 中華普通外科學文獻(電子版),2019,13(1): 1-15.
［26］ 中華醫學會內分泌學分會 ， 中華醫學會外科學分會 ， 中國抗癌協會頭頸腫瘤專業委員會 ， 等.甲狀腺結節和分化型甲狀腺癌診治指南［J］.中國腫瘤臨床,2012,39(17): 1249-1272.
［27］ 中國醫師協會外科醫師分會甲狀腺外科醫師委員會,中國研究型醫院學會甲狀腺疾病專業委員會,中國醫學裝備協會外科裝備分會甲狀腺外科裝備委員會.超聲引導下甲狀腺結節細針穿刺活檢專家共識及操作指南(2018版)［J］. 中國實用外科雜志, 2018, 38(3): 241-244.

• 疫苗|【992 | 速看】傳播能力有所增強！有關奧密克戎變異株，最新解答來了！
• 血壓|主動脈夾層可奪命？這五類人是高危人群，需高度重視
• 肺炎|遵義120教你肺炎伴胸膜炎怎么辦
• 公司|羅欣藥業：子公司注射用美羅培南通過仿制藥一致性評價
• 范可尼|為什么會長白頭發？
• 常崇旺|【視頻回放】腦癱患者常用外科術式及適應癥
• 中國雄安官網1月14日電（李元闖）在雄安新區安新縣|家鄉雄安丨楊宏記：村民致富路上的“帶頭人”
• 致癌|十多種腫瘤與“吃”密切相關，看完請注意避開！
• 北京冬奧運動|國際奧委會：北京冬奧運動員村相關人員新冠疫苗接種率接近100%
• 深圳|廣東新增本土確診病例9例：深圳2例、珠海5例、中山1例、梅州1例